UVB represses melanocyte cell migration and acts through β-catenin.
Identifieur interne : 004311 ( Ncbi/Merge ); précédent : 004310; suivant : 004312UVB represses melanocyte cell migration and acts through β-catenin.
Auteurs : Juliette U. Bertrand [France] ; Valérie Petit [France] ; Elke Hacker [Australie] ; Irina Berlin [France] ; Nicholas K. Hayward [Australie] ; Marie Pouteaux [France] ; Evelyne Sage [France] ; David C. Whiteman [Australie] ; Lionel Larue [France]Source :
- Experimental dermatology [ 1600-0625 ] ; 2017.
Abstract
The exposure of skin to ultraviolet (UV) radiation can have both beneficial and deleterious effects: it can lead, for instance, to increased pigmentation and vitamin D synthesis but also to inflammation and skin cancer. UVB may induce genetic and epigenetic alterations and have reversible effects associated with post-translational and gene regulation modifications. β-catenin is a main driver in melanocyte development; although infrequently mutated in melanoma, its cellular localization and activity are frequently altered. Here, we evaluate the consequence of UVB on β-catenin in the melanocyte lineage. We report that in vivo, UVB induces cytoplasmic/nuclear relocalization of β-catenin in melanocytes of newborn mice and adult human skin. In mouse melanocyte and human melanoma cell lines in vitro, UVB increases β-catenin stability, accumulation in the nucleus and cotranscriptional activity, leading to the repression of cell motility and velocity. The activation of the β-catenin signalling pathway and its effect on migration by UVB are increased by an inhibitor of GSK3β, and decreased by an inhibitor of β-catenin. In conclusion, UVB represses melanocyte migration and does so by acting through the GSK3-β-catenin axis.
DOI: 10.1111/exd.13318
PubMed: 28191677
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000445
- to stream PubMed, to step Curation: 000443
- to stream PubMed, to step Checkpoint: 000443
Links to Exploration step
pubmed:28191677Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">UVB represses melanocyte cell migration and acts through β-catenin.</title>
<author><name sortKey="Bertrand, Juliette U" sort="Bertrand, Juliette U" uniqKey="Bertrand J" first="Juliette U" last="Bertrand">Juliette U. Bertrand</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Petit, Valerie" sort="Petit, Valerie" uniqKey="Petit V" first="Valérie" last="Petit">Valérie Petit</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hacker, Elke" sort="Hacker, Elke" uniqKey="Hacker E" first="Elke" last="Hacker">Elke Hacker</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland Institute of Medical Research, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berlin, Irina" sort="Berlin, Irina" uniqKey="Berlin I" first="Irina" last="Berlin">Irina Berlin</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hayward, Nicholas K" sort="Hayward, Nicholas K" uniqKey="Hayward N" first="Nicholas K" last="Hayward">Nicholas K. Hayward</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland Institute of Medical Research, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pouteaux, Marie" sort="Pouteaux, Marie" uniqKey="Pouteaux M" first="Marie" last="Pouteaux">Marie Pouteaux</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sage, Evelyne" sort="Sage, Evelyne" uniqKey="Sage E" first="Evelyne" last="Sage">Evelyne Sage</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Whiteman, David C" sort="Whiteman, David C" uniqKey="Whiteman D" first="David C" last="Whiteman">David C. Whiteman</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland Institute of Medical Research, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Larue, Lionel" sort="Larue, Lionel" uniqKey="Larue L" first="Lionel" last="Larue">Lionel Larue</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28191677</idno>
<idno type="pmid">28191677</idno>
<idno type="doi">10.1111/exd.13318</idno>
<idno type="wicri:Area/PubMed/Corpus">000445</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000445</idno>
<idno type="wicri:Area/PubMed/Curation">000443</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000443</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000443</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000443</idno>
<idno type="wicri:Area/Ncbi/Merge">004311</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">UVB represses melanocyte cell migration and acts through β-catenin.</title>
<author><name sortKey="Bertrand, Juliette U" sort="Bertrand, Juliette U" uniqKey="Bertrand J" first="Juliette U" last="Bertrand">Juliette U. Bertrand</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Petit, Valerie" sort="Petit, Valerie" uniqKey="Petit V" first="Valérie" last="Petit">Valérie Petit</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hacker, Elke" sort="Hacker, Elke" uniqKey="Hacker E" first="Elke" last="Hacker">Elke Hacker</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland Institute of Medical Research, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berlin, Irina" sort="Berlin, Irina" uniqKey="Berlin I" first="Irina" last="Berlin">Irina Berlin</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hayward, Nicholas K" sort="Hayward, Nicholas K" uniqKey="Hayward N" first="Nicholas K" last="Hayward">Nicholas K. Hayward</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland Institute of Medical Research, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pouteaux, Marie" sort="Pouteaux, Marie" uniqKey="Pouteaux M" first="Marie" last="Pouteaux">Marie Pouteaux</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sage, Evelyne" sort="Sage, Evelyne" uniqKey="Sage E" first="Evelyne" last="Sage">Evelyne Sage</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Whiteman, David C" sort="Whiteman, David C" uniqKey="Whiteman D" first="David C" last="Whiteman">David C. Whiteman</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland Institute of Medical Research, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Larue, Lionel" sort="Larue, Lionel" uniqKey="Larue L" first="Lionel" last="Larue">Lionel Larue</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay</wicri:regionArea>
<placeName><settlement type="city">Orsay</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Experimental dermatology</title>
<idno type="eISSN">1600-0625</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The exposure of skin to ultraviolet (UV) radiation can have both beneficial and deleterious effects: it can lead, for instance, to increased pigmentation and vitamin D synthesis but also to inflammation and skin cancer. UVB may induce genetic and epigenetic alterations and have reversible effects associated with post-translational and gene regulation modifications. β-catenin is a main driver in melanocyte development; although infrequently mutated in melanoma, its cellular localization and activity are frequently altered. Here, we evaluate the consequence of UVB on β-catenin in the melanocyte lineage. We report that in vivo, UVB induces cytoplasmic/nuclear relocalization of β-catenin in melanocytes of newborn mice and adult human skin. In mouse melanocyte and human melanoma cell lines in vitro, UVB increases β-catenin stability, accumulation in the nucleus and cotranscriptional activity, leading to the repression of cell motility and velocity. The activation of the β-catenin signalling pathway and its effect on migration by UVB are increased by an inhibitor of GSK3β, and decreased by an inhibitor of β-catenin. In conclusion, UVB represses melanocyte migration and does so by acting through the GSK3-β-catenin axis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28191677</PMID>
<DateCreated><Year>2017</Year>
<Month>02</Month>
<Day>13</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0625</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>26</Volume>
<Issue>10</Issue>
<PubDate><Year>2017</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Experimental dermatology</Title>
<ISOAbbreviation>Exp. Dermatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>UVB represses melanocyte cell migration and acts through β-catenin.</ArticleTitle>
<Pagination><MedlinePgn>875-882</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/exd.13318</ELocationID>
<Abstract><AbstractText>The exposure of skin to ultraviolet (UV) radiation can have both beneficial and deleterious effects: it can lead, for instance, to increased pigmentation and vitamin D synthesis but also to inflammation and skin cancer. UVB may induce genetic and epigenetic alterations and have reversible effects associated with post-translational and gene regulation modifications. β-catenin is a main driver in melanocyte development; although infrequently mutated in melanoma, its cellular localization and activity are frequently altered. Here, we evaluate the consequence of UVB on β-catenin in the melanocyte lineage. We report that in vivo, UVB induces cytoplasmic/nuclear relocalization of β-catenin in melanocytes of newborn mice and adult human skin. In mouse melanocyte and human melanoma cell lines in vitro, UVB increases β-catenin stability, accumulation in the nucleus and cotranscriptional activity, leading to the repression of cell motility and velocity. The activation of the β-catenin signalling pathway and its effect on migration by UVB are increased by an inhibitor of GSK3β, and decreased by an inhibitor of β-catenin. In conclusion, UVB represses melanocyte migration and does so by acting through the GSK3-β-catenin axis.</AbstractText>
<CopyrightInformation>© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bertrand</LastName>
<ForeName>Juliette U</ForeName>
<Initials>JU</Initials>
<AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Univ Paris-Sud, Univ Paris-Saclay, CNRS UMR 3347, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Equipe Labellisée Ligue Contre le Cancer, Orsay, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Petit</LastName>
<ForeName>Valérie</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Univ Paris-Sud, Univ Paris-Saclay, CNRS UMR 3347, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Equipe Labellisée Ligue Contre le Cancer, Orsay, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hacker</LastName>
<ForeName>Elke</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berlin</LastName>
<ForeName>Irina</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Univ Paris-Sud, Univ Paris-Saclay, CNRS UMR 3347, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Equipe Labellisée Ligue Contre le Cancer, Orsay, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hayward</LastName>
<ForeName>Nicholas K</ForeName>
<Initials>NK</Initials>
<AffiliationInfo><Affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pouteaux</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Univ Paris-Sud, Univ Paris-Saclay, CNRS UMR 3347, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Equipe Labellisée Ligue Contre le Cancer, Orsay, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sage</LastName>
<ForeName>Evelyne</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Univ Paris-Sud, Univ Paris-Saclay, CNRS UMR 3347, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Equipe Labellisée Ligue Contre le Cancer, Orsay, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Whiteman</LastName>
<ForeName>David C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo><Affiliation>Queensland Institute of Medical Research, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Larue</LastName>
<ForeName>Lionel</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-2010-6107</Identifier>
<AffiliationInfo><Affiliation>Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Univ Paris-Sud, Univ Paris-Saclay, CNRS UMR 3347, Orsay, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Equipe Labellisée Ligue Contre le Cancer, Orsay, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>05</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Denmark</Country>
<MedlineTA>Exp Dermatol</MedlineTA>
<NlmUniqueID>9301549</NlmUniqueID>
<ISSNLinking>0906-6705</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BIO inhibitor</Keyword>
<Keyword MajorTopicYN="N">CHIR99021 inhibitor</Keyword>
<Keyword MajorTopicYN="N">human skin</Keyword>
<Keyword MajorTopicYN="N">iCRT3 inhibitor</Keyword>
<Keyword MajorTopicYN="N">mouse skin</Keyword>
<Keyword MajorTopicYN="N">p38</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>02</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>2</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28191677</ArticleId>
<ArticleId IdType="doi">10.1111/exd.13318</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
<li>France</li>
</country>
<settlement><li>Orsay</li>
</settlement>
</list>
<tree><country name="France"><noRegion><name sortKey="Bertrand, Juliette U" sort="Bertrand, Juliette U" uniqKey="Bertrand J" first="Juliette U" last="Bertrand">Juliette U. Bertrand</name>
</noRegion>
<name sortKey="Berlin, Irina" sort="Berlin, Irina" uniqKey="Berlin I" first="Irina" last="Berlin">Irina Berlin</name>
<name sortKey="Larue, Lionel" sort="Larue, Lionel" uniqKey="Larue L" first="Lionel" last="Larue">Lionel Larue</name>
<name sortKey="Petit, Valerie" sort="Petit, Valerie" uniqKey="Petit V" first="Valérie" last="Petit">Valérie Petit</name>
<name sortKey="Pouteaux, Marie" sort="Pouteaux, Marie" uniqKey="Pouteaux M" first="Marie" last="Pouteaux">Marie Pouteaux</name>
<name sortKey="Sage, Evelyne" sort="Sage, Evelyne" uniqKey="Sage E" first="Evelyne" last="Sage">Evelyne Sage</name>
</country>
<country name="Australie"><noRegion><name sortKey="Hacker, Elke" sort="Hacker, Elke" uniqKey="Hacker E" first="Elke" last="Hacker">Elke Hacker</name>
</noRegion>
<name sortKey="Hayward, Nicholas K" sort="Hayward, Nicholas K" uniqKey="Hayward N" first="Nicholas K" last="Hayward">Nicholas K. Hayward</name>
<name sortKey="Whiteman, David C" sort="Whiteman, David C" uniqKey="Whiteman D" first="David C" last="Whiteman">David C. Whiteman</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004311 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004311 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:28191677 |texte= UVB represses melanocyte cell migration and acts through β-catenin. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28191677" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |